These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1. Lose F, Duffy DL, Kay GF, Kedda MA, Spurdle AB, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Australian Ovarian Cancer Study Management Group. J Natl Cancer Inst; 2008 Nov 05; 100(21):1519-29. PubMed ID: 18957670 [Abstract] [Full Text] [Related]
5. High incidence of skewed X chromosome inactivation in young patients with familial non-BRCA1/BRCA2 breast cancer. Kristiansen M, Knudsen GP, Maguire P, Margolin S, Pedersen J, Lindblom A, Ørstavik KH. J Med Genet; 2005 Nov 05; 42(11):877-80. PubMed ID: 15879497 [Abstract] [Full Text] [Related]
8. CGH analysis of familial non-BRCA1/BRCA2 breast tumors and mutation screening of a candidate locus on chromosome 17q11.2-12. Maguire P, Holmberg K, Kost-Alimova M, Imreh S, Skoog L, Lindblom A. Int J Mol Med; 2005 Jul 05; 16(1):135-41. PubMed ID: 15942690 [Abstract] [Full Text] [Related]
9. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families. Durocher F, Labrie Y, Soucy P, Sinilnikova O, Labuda D, Bessette P, Chiquette J, Laframboise R, Lépine J, Lespérance B, Ouellette G, Pichette R, Plante M, Tavtigian SV, Simard J. BMC Cancer; 2006 Sep 29; 6():230. PubMed ID: 17010193 [Abstract] [Full Text] [Related]
13. Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents. Andres JL, Fan S, Turkel GJ, Wang JA, Twu NF, Yuan RQ, Lamszus K, Goldberg ID, Rosen EM. Oncogene; 1998 Apr 30; 16(17):2229-41. PubMed ID: 9619832 [Abstract] [Full Text] [Related]
14. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers. Walker LC, Waddell N, Ten Haaf A, kConFab Investigators, Grimmond S, Spurdle AB. Breast Cancer Res Treat; 2008 Nov 30; 112(2):229-36. PubMed ID: 18095154 [Abstract] [Full Text] [Related]
17. Mutation analysis of the ATR gene in breast and ovarian cancer families. Heikkinen K, Mansikka V, Karppinen SM, Rapakko K, Winqvist R. Breast Cancer Res; 2005 Nov 30; 7(4):R495-501. PubMed ID: 15987455 [Abstract] [Full Text] [Related]
18. Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families of Eastern Spain. Esteban Cardeñosa E, Bolufer Gilabert P, Palanca Suela S, Oltra Soler S, Barragán González E, Velasco Sampedro E, Chirivella González I, Segura Huerta A, Guillén Ponce C, Martínez de Dueñas E, Group for Assessment of Hereditary Cancer of Valencia Community. Breast Cancer Res Treat; 2008 Nov 30; 112(1):69-73. PubMed ID: 18060494 [Abstract] [Full Text] [Related]
19. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer. Potapova A, Hoffman AM, Godwin AK, Al-Saleem T, Cairns P. Cancer Res; 2008 Feb 15; 68(4):998-1002. PubMed ID: 18281473 [Abstract] [Full Text] [Related]